Provention Bio, Inc.
Methods and Compositions for Reducing Immunogenicity By Non-Depletional B Cell Inhibitors

Abstract:

Disclosed herein, in one aspect, is a method of reducing immunogenicity, comprising administering to a patient receiving or having received a biological therapeutic agent, an effective amount of B cell inhibitor that is non-depletional. Related compositions are also provided.